Lisheng Pharmaceutical: Net profit is expected to increase by 126.72% to 418 million yuan by 2025, influenced by dividends from associated companies.

2026-03-10 09:18:40

Abstract generation in progress

Recently, Lisheng Pharmaceutical announced that its 2025 performance quick report shows the company achieved a total operating revenue of 1.393 billion yuan, an increase of 4.23% year-on-year. The net profit attributable to shareholders was approximately 418 million yuan, a growth of 126.72%.

The announcement mentioned that in 2025, the company actively expanded its market and increased product sales. Additionally, the significant growth in total profit and net profit attributable to shareholders was influenced by dividends from affiliated companies.

(Lisheng Pharmaceutical Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes